Talkin’ baht summat like a micropancreas:
Betalin Therapeutics said its “bio-artificial” pancreas aims to free patients of the need for insulin injections and blood sugar monitoring. It is designed for people with type 1 type 2 diabetes who require insulin.
The Guardian’s arts graduates thinking that there is a type 2 of type 1 diabetes. Which is not – at least this social sciences graduate doesn’t think so – quite how it works.